Comparison of Brugger's Relief Exercises Versus Kinesio Taping at Craniovertebral Angle on Forward Head Posture
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 20, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different treatments can help improve forward head posture, a common issue where the head leans forward, causing strain on the neck. The researchers want to compare the effects of Brugger's Relief Exercises and Kinesio Taping on the angle of the neck where it meets the spine. The study is taking place at a physical therapy clinic in Islamabad and includes 28 participants aged between 20 and 40. To join the study, individuals must have a craniovertebral angle (a measurement of head position) of less than 50 degrees and not have any other serious neck or spine conditions.
Participants can expect to be divided into two groups: one will do Brugger's Relief Exercises while the other will receive Kinesio Taping. The trial will last for six months, and the researchers will use a special app to measure improvements in posture. Importantly, individuals with certain medical conditions or those currently receiving physical therapy are not eligible to participate. This study aims to find out which treatment is more effective for improving forward head posture, ultimately helping people feel better and reduce neck strain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both gender
- • Patients whose age lies between 20 and 40
- • Forward head posture with craniovertebral angle less than 50° degrees
- Exclusion Criteria:
- • Individuals with pre-existing musculoskeletal conditions affecting posture e.g. scoliosis, Scheuermann's disease.
- • Those currently undergoing physical therapy or other posture correction treatments.
- • Pregnant individuals, due to potential physiological changes affecting posture.
- • Subjects with a history of significant spinal or neck injuries.
- • No neurological disease (e.g. cervical radiculopathy, SCI).
- • Patients were excluded who shows positive result to spurling test, ULTT, Allen test.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Patients applied
Trial Officials
Asmar Fatima, MS-OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported